BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34726618)

  • 1. [Metabolic Stone assessment: Underused tool and how to implement it on daily practice.].
    Castro Henríquez E
    Arch Esp Urol; 2021 Nov; 74(9):823-834. PubMed ID: 34726618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which Diet for Calcium Stone Patients: A Real-World Approach to Preventive Care.
    D'Alessandro C; Ferraro PM; Cianchi C; Barsotti M; Gambaro G; Cupisti A
    Nutrients; 2019 May; 11(5):. PubMed ID: 31137803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk factors for urolithiasis].
    Mohebbi N
    Ther Umsch; 2021 Jun; 78(5):223-227. PubMed ID: 34032133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease.
    Jung H; Andonian S; Assimos D; Averch T; Geavlete P; Kohjimoto Y; Neisius A; Philip J; Saita A; Shah H; Osther PJ
    World J Urol; 2017 Sep; 35(9):1331-1340. PubMed ID: 28160089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and kidney stone disease: a systematic review.
    Carbone A; Al Salhi Y; Tasca A; Palleschi G; Fuschi A; De Nunzio C; Bozzini G; Mazzaferro S; Pastore AL
    Minerva Urol Nefrol; 2018 Aug; 70(4):393-400. PubMed ID: 29856171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for subsequent stone events in pediatric nephrolithiasis: A multi-institutional analysis.
    Medairos R; Paloian NJ; Pan A; Moyer A; Ellison JS
    J Pediatr Urol; 2022 Feb; 18(1):26.e1-26.e9. PubMed ID: 34980558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Risk of Chronic Kidney Disease Associated with Urolithiasis and its Urological Treatments: A Review.
    Gambaro G; Croppi E; Bushinsky D; Jaeger P; Cupisti A; Ticinesi A; Mazzaferro S; D'Addessi A; Ferraro PM
    J Urol; 2017 Aug; 198(2):268-273. PubMed ID: 28286070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why is diagnosis, investigation, and improved management of kidney stone disease important? Non-pharmacological and pharmacological treatments for nephrolithiasis.
    D'Ambrosio V; Moochhala S; Unwin RJ; Ferraro PM
    Expert Rev Clin Pharmacol; 2022 Apr; 15(4):407-414. PubMed ID: 35612529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LITHOSCREEN: a comprehensive screening program and database for the assessment and treatment management of patients with kidney stones.
    Robertson WG
    Urolithiasis; 2021 Oct; 49(5):387-397. PubMed ID: 34086105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ability of a limited metabolic assessment to identify pediatric stone formers with metabolic abnormalities.
    Chan KH; Moser EA; Whittam BM; Misseri R; Cain MP; Krambeck A
    J Pediatr Urol; 2018 Aug; 14(4):331.e1-331.e6. PubMed ID: 30177386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A diagnostic-therapeutic pathway for patients with kidney stone disease: 2020 update].
    Cupisti A; Trinchieri A; Lombardi M; Agostini S; Arcidiacono T; Beltrami P; Berri E; Bevilacqua L; Campo S; Cannavò R; Croppi E; Casarrubea G; Caviglioli C; Crisci A; D'Addessi A; Sio M; Fantuzzi A; Fusaro M; Gambaro G; Garofalo M; Micali S; Marangella M; Petrarulo M; Piccinocchi G; Sessa A; Tasca A; Vezzoli G; Vitale C; Zattoni F;
    G Ital Nefrol; 2020 Aug; 37(Suppl 75):. PubMed ID: 32749084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management.
    Sakhaee K; Maalouf NM; Sinnott B
    J Clin Endocrinol Metab; 2012 Jun; 97(6):1847-60. PubMed ID: 22466339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Syndrome and Kidney Stone Disease: A Systematic Review of Literature.
    Wong Y; Cook P; Roderick P; Somani BK
    J Endourol; 2016 Mar; 30(3):246-53. PubMed ID: 26576717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role, importance and assessment of dietary habits in urolithiasis patient.
    Yitgin Y; Asrak H; Tefik T
    World J Urol; 2023 May; 41(5):1229-1233. PubMed ID: 36697917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic evaluation: is there really a future?
    Traxer O; Corrales M; Sierra A
    Curr Opin Urol; 2022 Jul; 32(4):373-378. PubMed ID: 35674681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International Alliance of Urolithiasis (IAU) guidelines on the metabolic evaluation and medical management of urolithiasis.
    Zeng G; Zhu W; Robertson WG; Penniston KL; Smith D; Pozdzik A; Tefik T; Prezioso D; Pearle MS; Chew BH; Veser J; Fiori C; Deng Y; Straub M; Türk C; Semins MJ; Wang K; Marangella M; Jia Z; Zhang L; Ye Z; Tiselius HG; Sarica K
    Urolithiasis; 2022 Dec; 51(1):4. PubMed ID: 36454329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney and Ureteral Stones.
    Corbo J; Wang J
    Emerg Med Clin North Am; 2019 Nov; 37(4):637-648. PubMed ID: 31563199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Work-up of Patients with Urolithiasis: Indications and Diagnostic Algorithm.
    Tiselius HG; Daudon M; Thomas K; Seitz C
    Eur Urol Focus; 2017 Feb; 3(1):62-71. PubMed ID: 28720369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical treatment of renal stones.
    López Martínez JM; Sierra Del Rio A; Luque Galvez MP
    Arch Esp Urol; 2021 Jan; 74(1):63-70. PubMed ID: 33459622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.